Cellular immune response in HCV infection.
Nakamura
I
I
Division of Gastroenterology and Hepatology, Omiya Medical Center, Jichi Medical School, Japan.
Imawari
M
M
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D016174:Hepacivirus / Q000276:immunology*; D006526:Hepatitis C / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D016898:Interferon-alpha / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D019948:Receptors, Interleukin-4 / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D000998:Antiviral Agents; D016898:Interferon-alpha; D019948:Receptors, Interleukin-4; D018664:Interleukin-12; D016899:Interferon-beta; D007371:Interferon-gamma